Autoantibodies

797.4K

views

607

authors

89

articles

Autoantibodies

797.4K

views

607

authors

89

articles

Editorial

02 April 2019

Editorial: Autoantibodies

Rikard Holmdahl

,

Falk Nimmerjahn

and

Ralf J. Ludwig

7,916 views

4 citations

Editors

3

University of Lübeck

Rikard Holmdahl

Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet (KI)

Falk Nimmerjahn

University of Erlangen Nuremberg

Impact

Fetching...

About

Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to the manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves’ disease. Overall, more than 2.5% of the population is affected by autoantibody-driven autoimmune disease. Pathways leading to autoantibody-induced pathology greatly differ among different diseases, and autoantibodies directed against the same antigen, depending on the targeted epitope, can have diverse effects.

To foster knowledge in autoantibody-induced pathology and to encourage the development of urgently needed novel therapeutic strategies, we hope to stimulate a vivid discussion and interest in autoantibody-mediated diseases.

This Research Topic will comprise of Review and Original Research articles considering all aspects of autoantibodies. This includes their generation, morphology (i.e. glycosylation status) in health and disease, as well as the diverse mechanisms by which they lead to the induction of clinically overt autoimmune disease.

Autoantibodies are frequently observed in healthy individuals. In a minority of these individuals, they lead to the manifestation of autoimmune diseases, such as rheumatoid arthritis or Graves’ disease. Overall, more than 2.5% of the population is affected by autoantibody-driven autoimmune disease. Pathways leading to autoantibody-induced pathology greatly differ among different diseases, and autoantibodies directed against the same antigen, depending on the targeted epitope, can have diverse effects.

To foster knowledge in autoantibody-induced pathology and to encourage the development of urgently needed novel therapeutic strategies, we hope to stimulate a vivid discussion and interest in autoantibody-mediated diseases.

This Research Topic will comprise of Review and Original Research articles considering all aspects of autoantibodies. This includes their generation, morphology (i.e. glycosylation status) in health and disease, as well as the diverse mechanisms by which they lead to the induction of clinically overt autoimmune disease.

Download ebook

Share

Editors

University of Lübeck

Rikard Holmdahl

Division of Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet (KI)

Falk Nimmerjahn

University of Erlangen Nuremberg

Impact

797,393 Total views

591,994 Article views

195,424 Article downloads

9,975 Topic views

Published In

Journal Thumbnail

Frontiers in Immunology

Multiple Sclerosis and Neuroimmunology, B Cell Biology, T Cell Biology, Immunological Tolerance and Regulation, Inflammation, Cytokines and Soluble Mediators in Immunity, Molecular Innate Immunity, Autoimmune and Autoinflammatory Disorders

Journal Thumbnail

Frontiers in Neurology

Multiple Sclerosis and Neuroimmunology

Journal Thumbnail

Frontiers in Medicine

Dermatology, Rheumatology

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic